NEW YORK (Reuters Health) – Adding bevacizumab (Avastin, Genentech) to standard carboplatin and paclitaxel chemotherapy offers little clinical benefit in patients aged 65 and older with non-small cell…
NEW YORK (Reuters Health) – Older patients with small localized kidney tumors treated with partial nephrectomy live longer than those treated with radical nephrectomy, a new study suggests.…
NEW YORK (Reuters Health) – In patients with ST-segment elevation MI undergoing percutaneous coronary intervention, dilatation with the DIOR drug-eluting balloon (DEB) before implantation of a bare metal…
NEW YORK (Reuters Health) – Women older than age 30 are no more likely than younger women to develop hypothyroidism in pregnancy, suggest results a study from the…
NEW YORK (Reuters Health) – While the use of triclosan-impregnated sutures has been widely endorsed, they do not reduce the rate of surgical site infections, according to the…
NEW YORK (Reuters Health) – Long-term improvement in glycemic control seen with real-time continuous glucose monitoring (CGM) is similar whether used in a patient self-management protocol or in…
NEW YORK (Reuters Health) – In patients with moderate-to-severe chronic obstructive pulmonary disease, twice daily inhalation of either 200 or 400 mcg aclidinium bromide significantly improves FEV1, and…
NEW YORK (Reuters Health) – A meta-analysis of individual patient data found no differences in overall survival, progression-free survival, and objective response rate between cisplatin- and carboplatin-based chemotherapy…
NEW YORK (Reuters Health) – In looking back at more than 30,000 patients who had major open abdominal surgery over a five-year period, researchers found that those who…
NEW YORK (Reuters Health) – Therapeutic oral anticoagulation with warfarin, without extra heparins, provides sufficient anticoagulation for patients on long-term warfarin who need primary percutaneous coronary intervention (PCI),…
